WELCOME TO THE MANUFACTURING REPORT
Newsletter | Member Login | Signup
Home > Companies > Mitsui & Co., Ltd.
Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...
Conference
Mitsui Chemicals | March 27, 2018
Mitsui Chemicals, Inc. will start construction of a manufacturing facility for Milastomer thermoplastic vulcanizate (TPV) at its affiliate and polypropylene compounder Advanced Composites, Inc. in Sidney, Ohio, in January next year. The 6,000-tonnes/year production plant is slated for completion in June 2019, with operational startup slated for October. The primary ingredients of Milastomer thermoplastic olefin elastomer are olefin rubber and olefin resin. With its low density, lightweigh...
FIT AG | July 11, 2019
FIT Additive Manufacturing Group is to offer its additive capabilities to the Japanese market through Mitsui & Co. Machine Tech Ltd, a fellow 3D printing service provider. The companies announced the formation of their partnership at the German-Japanese Additive Manufacturing Forum, hosted by the German Chamber of Commerce in Japan. FIT was founded in 1995 as a manufacturing service bureau and has continually increased its adoption of additive technologies to supplement its subtractive offer...
Keppel Offshore & Marine, Lloyd's Register | January 14, 2020
Keppel Offshore & Marine has received Lloyd’s Register LR Certification to additively manufacture offshore grade steel with a 3D printing technology from Singapore Institute of Manufacturing Technology SIMTech. The certification was granted after assessing Keppel O&M’s production processes, from design to post-processing and testing. Partnering with Nanyang Technological University, Singapore NTU Singapore and SIMTech’s Agency for Science, Technology and Research A*STAR...
Outsourcing-Pharma.com | January 13, 2020
BMS and Catalent disclosed the deal for the site in June, at which time they hoped to work through the regulatory approvals and union consultations needed to close the transaction by the end of the year. One week into 2020, Bristol-Myers revealed it had closed the deal. The deal covers a 19,300-square-meter manufacturing facility in Anagni, a town in central Italy, that lists cardiovascular, neuroleptics, anticancer, metabolic and anti-inflammatory medicines among the drugs it makes and packages...
Manufacturing Technology
Whitepaper
Industrial 4.0
infographic
Keep me plugged in with the best
Join thousands of your peers and receive our weekly newsletter with the latest news, industry events, customer insights, and market intelligence.
Welcome back!
Put your news, events, company, and promotional content in front of thousands of your peers and potential customers.
Not a member yet? Not a problem, Sign Up
Sign up
Sign up to contribute and publish your news, events, brand, and content with the community for FREE